Charles River Laboratories is on the cusp of releasing its fourth-quarter earnings report, with analysts anticipating a low–double-digit drop in year-over-year earnings. Investors and industry observers alike are watching closely to see how these figures will shape the company’s trajectory going forward.

The State of Wyoming grew its position in Charles River Laboratories International, Inc. by 16.5% during the first quarter. Official reports show the state acquired 208 additional shares, bringing its total holdings to 1,468 shares in the medical research company.